Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20122
20132
20142
20172
20182
20192
20201
20217
20225
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting11
Completed10
Recruiting6
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Pfizer4
Vertex Pharmaceuticals Incorporated4
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Seagen Inc.2
Takeda2
Amgen1
Ariad Pharmaceuticals1
BioMarin Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases31
Bone Marrow Diseases7
Genetic Diseases, Inborn7
Hemorrhagic Disorders7
Anemia, Sickle Cell6
Lymphoma, Non-Hodgkin6
Hemoglobinopathies5
Lymphoma, B-Cell5
Anemia4
Blood Coagulation Disorders4

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.